Claude Benchimol, SVP, Research & Development at INVITROGEN CORP (IVGN), sold 1,031 shares at $91.40 ($94K) on 2007-11-19, disclosed to the SEC on 2007-12-04.
Open-market sale of $94k IVGN by SVP, Research & Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.